• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动免疫监测项目:一种疫苗安全性主动监测模式

Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.

作者信息

Scheifele David W, Halperin Scott A

机构信息

Immunization Monitoring Program, Active (IMPACT), Ottawa, Ontario, Canada.

出版信息

Semin Pediatr Infect Dis. 2003 Jul;14(3):213-9. doi: 10.1016/s1045-1870(03)00036-0.

DOI:10.1016/s1045-1870(03)00036-0
PMID:12913834
Abstract

In Canada since 1993 the nation's passive system for reporting postimmunization adverse events has been supplemented by the active surveillance of inpatients at 10 to 12 pediatric referral centers, a system referred to as the Immunization Monitoring Program, Active. Participating centers are located from coast-to-coast and receive referrals from every province and territory. Approximately 20 percent of the population aged 0 to 12 years lives in the immediate vicinity of these centers. Nurse monitors at each center search for numerous target conditions, including postimmunization adverse events and vaccine-preventable infections. Vaccine safety observations have included (1) a substantial decrease in the risk of the development of febrile seizures and hypotonic-hyporesponsive episodes since the country switched from whole-cell to acellular pertussis-containing vaccines, (2) no evidence for encephalopathy resulting from the latter vaccines, (3) a generally benign outcome with postimmunization thrombocytopenia cases, and (4) an unexpectedly high rate of disseminated bacille Calmette-Guérin infections among aboriginal infants. Concomitant disease surveillance has been important for sustaining the surveillance system because few postimmunization adverse events require hospital admission.

摘要

自1993年以来,加拿大全国性的免疫接种后不良事件被动报告系统得到了10至12个儿科转诊中心对住院患者进行主动监测的补充,该系统被称为主动免疫监测项目。参与的中心遍布全国,接收来自每个省和地区的转诊患者。0至12岁的人口中约有20%居住在这些中心的附近。每个中心的护士监测员会查找多种目标病症,包括免疫接种后不良事件和疫苗可预防感染。疫苗安全性观察结果包括:(1)自该国从全细胞百日咳疫苗改用含无细胞百日咳疫苗以来,热性惊厥和低张性低反应性发作的发生风险大幅降低;(2)没有证据表明后一种疫苗会导致脑病;(3)免疫接种后血小板减少症病例的总体预后良好;(4)原住民婴儿中播散性卡介苗感染率意外偏高。伴随疾病监测对于维持监测系统很重要,因为很少有免疫接种后不良事件需要住院治疗。

相似文献

1
Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.主动免疫监测项目:一种疫苗安全性主动监测模式
Semin Pediatr Infect Dis. 2003 Jul;14(3):213-9. doi: 10.1016/s1045-1870(03)00036-0.
2
Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.加拿大自改用无细胞百日咳疫苗后,发热性惊厥的住院人数减少,且向医院急诊科报告的低渗性低反应性发作病例减少:来自IMPACT的一份报告
Pediatrics. 2003 Nov;112(5):e348. doi: 10.1542/peds.112.5.e348.
3
Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.加拿大与卡介苗相关的严重不良事件。
Pediatr Infect Dis J. 2005 Jun;24(6):538-41. doi: 10.1097/01.inf.0000164769.22033.2c.
4
Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010.
Commun Dis Intell Q Rep. 2011 Mar;35(1):21-8. doi: 10.33321/cdi.2011.35.5.
5
Surveillance of adverse events following immunisation: Australia, 2000-2002.2000 - 2002年澳大利亚免疫接种后不良事件监测
Commun Dis Intell Q Rep. 2003;27(3):307-23.
6
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).美国婴儿接种无细胞百日咳疫苗:对疫苗不良事件报告系统(VAERS)头两年数据的评估。
Pediatrics. 2000 Oct;106(4):E51. doi: 10.1542/peds.106.4.e51.
7
Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004.2004年1月1日至6月30日对7岁以下儿童免疫接种后不良事件的监测。
Commun Dis Intell Q Rep. 2004;28(4):490-2. doi: 10.33321/cdi.2004.28.54.
8
Vaccine-related adverse events in Cuban children, 1999-2008.1999-2008 年古巴儿童的疫苗相关不良事件。
MEDICC Rev. 2012 Jan;14(1):38-43. doi: 10.37757/MR2012V14.N1.8.
9
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.年龄对儿童麻疹疫苗接种后发热和惊厥风险的影响。
JAMA Pediatr. 2013 Dec;167(12):1111-7. doi: 10.1001/jamapediatrics.2013.2745.
10
Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.1996 - 1998年向疫苗不良事件报告系统(VAERS)报告的低渗性低反应发作情况。
Pediatrics. 2000 Oct;106(4):E52. doi: 10.1542/peds.106.4.e52.

引用本文的文献

1
National safety monitoring of vaccines from the Canadian Adverse Events Following Immunization Surveillance System (CAEFISS), 2018-2019.2018 - 2019年加拿大免疫后不良事件监测系统(CAEFISS)对疫苗的国家安全监测。
Can Commun Dis Rep. 2024 Jan 1;50(1-2):49-57. doi: 10.14745/ccdr.v50i12a06.
2
Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.2021 - 2022年加拿大季节性流感疫苗免疫接种后的疫苗安全性监测报告
Can Commun Dis Rep. 2024 Jan 1;50(1-2):16-24. doi: 10.14745/ccdr.v50i12a02.
3
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial.
比较移动应用程序和基于网络的通知平台在流感疫苗接种后不良事件监测中的使用:随机对照试验。
JMIR Public Health Surveill. 2023 May 8;9:e39700. doi: 10.2196/39700.
4
The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada.加拿大国家疫苗安全网络:在加拿大进行的一项队列研究,监测接种 COVID-19 疫苗人群的疫苗接种后不良反应事件。
BMJ Open. 2022 Jan 20;12(1):e051254. doi: 10.1136/bmjopen-2021-051254.
5
Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia.对急性儿科住院病例的主动监测,展示了疫苗接种计划在加拿大和澳大利亚的影响,并为疫苗政策提供了信息。
Euro Surveill. 2020 Jun;25(25). doi: 10.2807/1560-7917.ES.2020.25.25.1900562.
6
2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.2017/18 年和 2018/19 年季节性流感疫苗安全性监测,加拿大国家疫苗安全(CANVAS)网络。
Euro Surveill. 2020 Jun;25(22). doi: 10.2807/1560-7917.ES.2020.25.22.1900470.
7
Vaccine safety surveillance in Canada: Reports to CAEFISS, 2013-2016.加拿大的疫苗安全监测:2013 - 2016年提交给加拿大疫苗安全信息系统的报告
Can Commun Dis Rep. 2018 Sep 6;44(9):206-214. doi: 10.14745/ccdr.v44i09a04.
8
Developing a vaccine for serotype a: Proceedings of a workshop.开发针对A血清型的疫苗:研讨会会议记录
Can Commun Dis Rep. 2017 May 4;43(5):89-95. doi: 10.14745/ccdr.v43i05a02.
9
The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.加拿大免疫监测项目,即主动监测(IMPACT):对疫苗不良事件和疫苗可预防疾病进行主动监测。
Can Commun Dis Rep. 2014 Dec 4;40(Suppl 3):41-44. doi: 10.14745/ccdr.v40is3a06.
10
Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012.加拿大免疫接种后不良事件监测系统(CAEFISS):2012年疫苗接种年度报告。
Can Commun Dis Rep. 2014 Dec 4;40(Suppl 3):7-23. doi: 10.14745/ccdr.v40is3a02.